Biotech
| Website | http://www.immunemed.co.kr |
| Revenue | $6.3 million |
| Employees | 6 (2 on RocketReach) |
| Founded | 2000 |
| Address | 7605 Business Incubation Centerhallym Universityokcheon-dong, Chuncheon, Gangwon-do, KR |
| Phone | +82 33-258-6551 |
| Technologies | |
| Industry | Biotechnology Research, Electronics, Manufacturing |
| Keywords | Immunotherapy, Biotechnology, Immunology, Biopharma, Drug Discovery, Therapeutics, Biologics, Drug Development, Life Sciences, Pharmaceutical, Pharmaceutical Research, Biotech Research, Innovative Therapies, Clinical Trials, Precision Medicine, Healthcare, Cancer Treatment, Cell Therapy, Gene Therapy, Medical Research |
| Competitors | Moderna Therapeutics, Pfizer, AstraZeneca, Novavax, GSK, Sanofi, Johnson & Johnson, Bristol Myers Squibb, Merck & Co., Inc., Eisai Co., Ltd. +40 more (view full list) |
| SIC | SIC Code 36 Companies, SIC Code 367 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular ImmuneMed Inc. employee's phone or email?
The ImmuneMed Inc. annual revenue was $6.3 million in 2026.
Young Choi is the Managing Director. 상무 of ImmuneMed Inc..
2 people are employed at ImmuneMed Inc..
ImmuneMed Inc. is based in Chuncheon, Gangwon-do.
The NAICS codes for ImmuneMed Inc. are [33, 334].
The SIC codes for ImmuneMed Inc. are [36, 367].